GlassScriptPhysician profile
Blake A Mcmillan
NPI 1356330153
$866.94
in general payments reported to CMS, 2019-2025
17 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.15 · 2022: $118 · 2023: $357 · 2024: $68.95 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $109.59 | 2025 | Tornier Perform Reversed Augmented Glenoid, Tornier Perform Reversed Glenoid |
| Globus Medical, INC. | $97.65 | 2022-2023 | Clavicular Fracture Fixation |
| Bioventus LLC | $90.92 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane, Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $85.23 | 2023-2025 | Physio-Stim |
| Smith+Nephew, INC. | $74.94 | 2023 | Pico 7 |
| Depuy Synthes Sales INC. | $73.46 | 2022-2023 | Monovisc, Orthovisc, Peak |
| Si-Bone, INC. | $71.36 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $50.17 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $41.67 | 2025 | Exparel |
| Ferring Pharmaceuticals INC. | $31.86 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $28.42 | 2023 | Seglentis |
| Vericel Corporation | $24.81 | 2021 | |
| Kci USA, INC. | $24.45 | 2023 | Prevena |
| Solventum Corporation | $17.21 | 2024 | V.A.C. Veraflo, Prevena |
| Amgen INC. | $16.16 | 2024 | Krystexxa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.12 | 2025 | Bexsero, Shingrix, Arexvy |
| Ethicon US, LLC | $13.92 | 2025 | Ethicon, Vistaseal, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Mcmillan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.